nach oben

Reactions Weekly

Erschienen in:

01.06.2018 | Case report

Tocilizumab

Erythematous skin reaction at the injection site: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

In a retrospective study involving 88 patients, one patient [age and sex not stated] was described, who developed erythematous skin reaction at the injection site following treatment with tocilizumab. The patient received infusion of tocilizumab [dosage not stated] for rheumatoid arthritis. The patient developed erythematous skin reaction at the injection site [duration of treatment to reaction onset and outcome not stated] and the tocilizumab injections were stopped. …

Chopin C, et al. Effectiveness, therapeutic maintenance and reasons for stopping tocilizumab (TCZ): A retrospective and monocentric study in 88 patients followed for rheumatoid arthritis (RA) at the Reims university hospital. Therapie 73: 231-236, No. 3, Jun 2018. Available from: URL: http://doi.org/10.1016/j.therap.2017.08.004 - FranceCrossRefPubMed

Titel: Tocilizumab
Erythematous skin reaction at the injection site: case report
Publikationsdatum: 01.06.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-48398-3

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Tocilizumab

Erythematous skin reaction at the injection site: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Lithium/thiocolchicoside/valproic acid

Tocilizumab

Diphtheria-tetanus-vaccine/unspecified meningococcal-vaccines

Atezolizumab/bevacizumab interaction

Alemtuzumab-induced thyroid dysfunction examined

Rivastigmine